Intrinsic value of CRISPR Therapeutics AG (CRSP)
Live fair value data for CRISPR Therapeutics AG (CRSP) is currently unavailable. Please check again shortly.
Current Price: $172.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is CRISPR Therapeutics AG (CRSP) undervalued or overvalued?
Based on the current model output, CRISPR Therapeutics AG appears to be undervalued with a upside of 65.00%.
Fair value vs market price — CRISPR Therapeutics AG (CRSP)
Unlock premium access to view the live fair value comparison against current market price for CRSP.
Frequently Asked Questions - CRSP
How is CRSP intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for CRSP.
Is CRSP undervalued or overvalued right now?
CRSP is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for CRSP: open their intrinsic value pages.